Diabetic retinopathy in the greater adult.
Abstract
A cross-sectional descriptive observational study was carried in the Diabetic Center of Ciego de Avila from June 2009 to June 2010, with the aim to determine the prevalence of diabetic retinopathy in elderly patients. The sample was integrated by 113 diabetic patients types I and II with diabetic retinopathy. An ophthalmological clinical history designed by the investigator to all patients was carried out to them. Diabetic retinopathy was pronounced with more frequency in patients between 60 and 69 years that 75.2% represented. 62.8% of Feminine sex predominated, and according to time of evolution of the disease those of more than 10 years prevailed, with 66 patients that constituted a 58.4% of the sample. The DM type II predominated with an 85.8%. Associate diseases were hypertension in 57.5%, primary open-angle glaucoma (27.4%) and high cholesterol (13.3%). No proliferative diabetic retinopathy appeared in 88 patients (77.9%).Downloads
Author Biographies
Elizabeth Morffi González
Yohany Díaz Díaz
Vicente Fernández Pérez
Karinne Peña Hernández
Carlos Alberto Pérez Padilla
References
Jácome Roca A. Diabetes al día. Hispanos diabéticos en América Latina y del norte [Internet]. 2012 [citado 12 Oct 2012] [aprox. 2 pantallas]. Disponible en: http://encolombia.com/medicina/sociedadescien/diabetes1201hispan osdiab.htm
Yau JW. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012; 35(3):556-64.
Beers MH, Porter RS, Jones TV, Kaplan JL, Berkwits M, editores. Diabetes mellitus y trastornos del metabolismo de los hidratos de carbono en: El Manual Merck de diagnóstico y tratamiento 11va ed. Madrid: Elseiver; 2006. p. 1390-94.
Socarrás Suárez M, Bolet Astoviza M, Licea Puig M. Diabetes mellitus: tratamiento dietético. Rev Cubana Invest Bioméd [Internet]. 2002 [citado 12 Oct 2012]; 21(2): [aprox. 5 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-03002002000200007&script= sci_arttext&tlng=en
Gónzalez Gómez SR. Diabetes mellitus. Rev Cubana Med [Internet]. 2005 [citado 12 Oct 2012]; 44(5-6): [aprox. 5 p.]. Disponible en: http:// scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232005000500008&lng=es&nrm=iso&tlng=es
Osorio Illas L, Paisán Rizo WM, Hitchman Barada D. Factores de riesgo asociados a la retinopatía diabética en pacientes diabéticos tipo II. Rev Cubana Med Gen Integr [Internet]. 2006 [citado 12 Oct 2012]; 22(1): [aprox. 4 p.]. Disponible en: http://scielo.sld.cu/scielo.php?pid=S0864-21252006000100016&script=sci_arttext&tlng=en
Cunha Vaz J. Lowering the risk of visual impairment and blindness. Diabet Med. 1998; 15 Suppl 4:S47-50.
Cugati S, Kifley A, Mitchell P, Wang JJ. Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: Population-based survey findings. Diabetes Res Clin Pract. 2006; 74(3):301-8.
Maylahn C, Gohdes D, Balamurugan A, Larsen B. Age-related eye diseases: an emerging challenge for public health professionals. Prev Chronic Dis. 2005; 2(3): A17.
Hietala K, Harjutsalo V, Forsblom C, Summanen P, Groop PH; FinnDiane Study Group. Age at onset and the risk of proliferative retinopathy in type 1 diabetes. Diabetes Care. 2010; 33(6):1315-9.
Crespo Valdés N, Padilla González JC, González Fernández R, Crespo Mojena N, Rodríguez Casales M, Hernández Beguiristain JD. Prevalencia de la retinopatía diabética en pacientes del nivel primario de salud. Rev Cubana Med Gen Integr [Internet]. 2004 [citado 12 Oct 2012]; 20(2): [aprox. 5 p.]. Disponible en: http://scielo.sld.cu/scielo.php? pid=S0864-21252004000200001&script= sci_arttext
Hernández Pérez A, Tirado Martínez O, Rivas Canino MC, Licea Puig M, Maciquez Rodríguez JE. Factores de riesgo en el desarrollo de la retinopatía diabética. Rev Cubana Oftalmol [Internet]. 2011 [citado 12 Oct 2012]; 24(1):[aprox. 7 p.]. Disponible en: http://scielo.sld.cu/scielo.Php? script=sci_arttext&pid=S086421762011000100009&lng=es&nrm=iso&tlng=es
Abbate R, Mannucci E, Cioni G, Fatini C, Marcucci R. Diabetes and sex: from pathophysiology to personalized medicine. Intern Emerg Med. 2012; 7(Suppl 3):215-9.
Harjutsalo V, Maric C, Forsblom C, Thorn L, Wadén J, Groop PH; FinnDiane Study Group. Sex-related differences in the long-term risk of microvascular complications by age at onset of type 1 diabetes. Diabetologia. 2011; 54(8):1992-9.
Wang FH, Liang YB, Zhang F, Wang JJ, Wei WB, Tao QS, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology. 2009; 116(3):461-7.
Sigler Villanueva A, Jímenez Barredo J, Gómez Carro R, Rodríguez Sánchez LA, Posada Fernández P, Maqueira Roque JM, et al. Análisis de algunas variables clínicas en relación con la retinopatía diabética. Rev Cubana Oftalmol. 1996; 9(2):122-127.
Li Y, Fan AZ, Balluz LS. Visual impairment and age-related eye diseases in Florida: findings from 2006 Behavioral Risk Factors Surveillance System (BRFSS) in nine states. Risk Manag Healthc Policy. 2009; 2:65-71. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270904/
Williams ME. The goal of blood pressure control for prevention of early diabetic microvascular complications. Curr Diabet Rep [Internet]. 2011 [citado 12 Oct 2012]; 11(4): 323-9. Disponible en: http://www.springerlink.com/index/X3674455857L6017.pdf
Anan F, Masaki T, Ito Y, Eto T, Umeno Y, Eshima N, et al. Diabetic retinopathy is associated with visceral fat accumulation in Japanese type 2 diabetes mellitus patients. Metabolism [Internet]. 2010 [citado 12 Oct 2012]; 59(3):314-9. Disponible en: http://www.sciencedirect.com/science/article/pii/S0026049509002467
Damkondwar DR, Raman R, Suganeswari G, Kulothungan V, Sharma T. Assessing Framingham cardiovascular risk scores in subjects with diabetes and their correlation with diabetic retinopathy. Indian J Ophthalmol [Internet]. 2012 [citado 12 Oct 2012]; 60(1):45-8. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263245/
Downloads
Published
How to Cite
Issue
Section
License
Those authors who have publications with this journal accept the following terms of the License CC Attribution-NonCommercial 4.0 International (CC BY-NC 4.0):
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes .
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
